(0.01%) 5 207.00 points
(0.04%) 39 011 points
(-0.06%) 18 184 points
(0.13%) $78.58
(-1.50%) $2.16
(-0.17%) $2 327.30
(-0.49%) $27.48
(0.39%) $968.65
(0.17%) $0.930
(0.32%) $10.86
(0.21%) $0.798
(0.34%) $91.65
3 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 13.14%
-0.19% $ 0.998
Live Chart Being Loaded With Signals
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers...
Stats | |
---|---|
Dzisiejszy wolumen | 65 726.00 |
Średni wolumen | 349 953 |
Kapitalizacja rynkowa | 43.21M |
EPS | $0 ( 2024-04-04 ) |
Następna data zysków | ( $-0.170 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.000 |
ATR14 | $0.00900 (0.90%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-07 | Epperly Corinne | Buy | 12 500 | Stock Option (right to buy) |
2024-02-07 | Ho William Tai-wei | Buy | 502 000 | Employee Stock Option (right to buy) |
2024-02-07 | Goswami Trishna | Buy | 176 000 | Employee Stock Option (right to buy) |
2024-02-07 | Rochlin Kate | Buy | 186 000 | Employee Stock Option (right to buy) |
2024-02-07 | Lamb Lawrence | Buy | 169 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
24.71 |
Last 98 transactions |
Buy: 9 531 383 | Sell: 5 834 681 |
Wolumen Korelacja
IN8bio, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
PCVX | 0.832 |
DTSS | 0.822 |
IMPL | 0.82 |
WHLR | 0.819 |
SLM | 0.816 |
AFYA | 0.815 |
JAZZ | 0.814 |
PDSB | 0.811 |
AVIR | 0.811 |
LIVN | 0.806 |
10 Najbardziej negatywne korelacje | |
---|---|
PAE | -0.843 |
RAVN | -0.832 |
NEO | -0.828 |
ZGNX | -0.813 |
SERA | -0.813 |
PEGA | -0.81 |
ACVA | -0.81 |
EBAC | -0.809 |
ICON | -0.808 |
TA | -0.807 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
IN8bio, Inc. Korelacja - Waluta/Towar
IN8bio, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.50M (0.00 %) |
EPS: | $-1.000 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.50M (0.00 %) |
EPS: | $-1.000 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.10M (0.00 %) |
EPS: | $-1.310 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.095 |
Financial Reports:
No articles found.
IN8bio, Inc.
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej